Quick Answer
ABBOTT LABORATORIES reported Total Revenue of $44.33 billion for the year ending 2025.
- ABBOTT LABORATORIES showed an increase of +5.7% in Total Revenue from 2024 to 2025.
- This data is from ABBOTT LABORATORIES's annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2017: $6.34 billion | Q2 2017: $6.64 billion | Q3 2017: $6.83 billion | Q4 2017: $7.59 billion | Q1 2018: $7.39 billion | Q2 2018: $7.77 billion | Q3 2018: $7.66 billion | Q4 2018: $7.77 billion | Q1 2019: $7.54 billion | Q2 2019: $7.98 billion | Q3 2019: $8.08 billion | Q4 2019: $8.31 billion | Q1 2020: $7.73 billion | Q2 2020: $7.33 billion | Q3 2020: $8.85 billion | Q1 2021: $10.46 billion | Q2 2021: $10.22 billion | Q3 2021: $10.93 billion | Q1 2022: $11.90 billion | Q2 2022: $11.26 billion | Q3 2022: $10.41 billion | Q1 2023: $9.75 billion | Q2 2023: $9.98 billion | Q3 2023: $10.14 billion | Q1 2024: $9.96 billion | Q2 2024: $10.38 billion | Q3 2024: $10.64 billion | Q1 2025: $10.36 billion | Q2 2025: $11.14 billion | Q3 2025: $11.37 billion.
- Over the full 10 years of available data (2016 to 2025), ABBOTT LABORATORIES's Total Revenue has grown by 112.6%.
- Historical annual values: Fiscal year 2025: $44.33 billion | Fiscal year 2024: $41.95 billion | Fiscal year 2023: $40.11 billion | Fiscal year 2022: $43.65 billion | Fiscal year 2021: $43.08 billion | Fiscal year 2020: $34.61 billion | Fiscal year 2019: $31.90 billion | Fiscal year 2018: $30.58 billion | Fiscal year 2017: $27.39 billion | Fiscal year 2016: $20.85 billion.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: